These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10701010)

  • 21. Cadaveric renal transplantation using donors over 60 years old--5 year follow-up.
    Vivas CA; Gritsch HA; Shapiro R; Scantlebury VP; Hickey DP; Hakala TR; Jordan ML
    Transplant Proc; 1997; 29(1-2):112. PubMed ID: 9122919
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of donor factors on development of hypertension following cadaveric renal transplantation in nonhypertensive recipients.
    Fleishhacker JF; Distant DA; Sumrani NB; Hong JH; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):418-9. PubMed ID: 8644299
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation from nonideal donors.
    Frutos MA; Cardona JG; González-Molina M; Cabello M; Burgos D; López de Novales E
    Transplant Proc; 1996 Dec; 28(6):3406-7. PubMed ID: 8962330
    [No Abstract]   [Full Text] [Related]  

  • 24. How to improve the quality of kidneys from non-heart-beating donors: a randomised controlled trial of thrombolysis in non-heart-beating donors.
    Gok MA; Shenton BK; Buckley PE; Peaston R; Cornell C; Soomro N; Jaques BC; Manas DM; Talbot D
    Transplantation; 2003 Dec; 76(12):1714-9. PubMed ID: 14688521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis in human kidney allografts.
    Matsuno T; Sasaki H; Ishido N; Nakagawa K; Ishikawa T; Oishi A; Inagaki M; Saito S; Yagi T; Haisa M; Tanaka N; Orita K
    Transplant Proc; 1996 Jun; 28(3):1226-7. PubMed ID: 8658636
    [No Abstract]   [Full Text] [Related]  

  • 26. Viability testing in the non-heart-beating donor.
    Light J
    Transplant Proc; 2000 Feb; 32(1):179-81. PubMed ID: 10701014
    [No Abstract]   [Full Text] [Related]  

  • 27. Pulsatile machine perfusion with Vasosol solution improves early graft function after cadaveric renal transplantation.
    Guarrera JV; Polyak M; O'Mar Arrington B; Kapur S; Stubenbord WT; Kinkhabwala M
    Transplantation; 2004 Apr; 77(8):1264-8. PubMed ID: 15114096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of acute tubular necrosis (ATN) by furosemide and steroids in cadaveric kidney recovery.
    McCabe R; Stevens LE; Subramamian A; Lattes C; Hashim GM
    Am J Surg; 1975 Mar; 129(3):246-8. PubMed ID: 1091177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-heart-beating donor transplantation: machine perfusion preservation is the answer to prolonged cold ischemia time.
    Rizvi SA
    Transplant Proc; 2000 Feb; 32(1):143. PubMed ID: 10701000
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety of a simple hypertonic solution with high potassium content for perfusion of renal cadaveric grafts: comparison with the University of Wisconsin perfusion solution.
    Salgado O; García R; Henríquez C; Terán N; Rubio L; Herrera J; Rodríguez-Iturbe B
    Transplant Proc; 1996 Dec; 28(6):3335-6. PubMed ID: 8962296
    [No Abstract]   [Full Text] [Related]  

  • 31. Usefulness of continuous hypothermic perfusion preservation for cadaveric renal grafts in poor condition.
    Kozaki K; Sakurai E; Tamaki I; Matsuno N; Saito A; Furuhashi K; Uchiyama M; Zhang S; Kozaki M
    Transplant Proc; 1995 Feb; 27(1):757-8. PubMed ID: 7879173
    [No Abstract]   [Full Text] [Related]  

  • 32. Organ donors: heartbeating and non-heartbeating.
    Kootstra G; Kievit J; Nederstigt A
    World J Surg; 2002 Feb; 26(2):181-4. PubMed ID: 11865348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of diltiazem in reducing the incidence of acute tubular necrosis in Euro-Collins-preserved cadaveric renal grafts.
    Puig JM; Lloveras J; Oliveras A; Costa A; Aubia J; Masramon J
    Transplant Proc; 1991 Oct; 23(5):2368-9. PubMed ID: 1926388
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of machine perfusion preservation in kidney transplantation from non-heartbeating donors.
    Matsuno N; Sakurai E; Uchiyama M; Kozaki K; Miyamoto K; Kozaki M; Nagao T
    Clin Transplant; 1998 Feb; 12(1):1-4. PubMed ID: 9541415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term renal preservation and prevention of acute tubular necrosis by inhibition of arachidonate metabolism.
    Schilling M; Saunder A; Southard JH; Belzer FO
    Transplant Proc; 1993 Aug; 25(4):2534-5. PubMed ID: 8356657
    [No Abstract]   [Full Text] [Related]  

  • 36. Post-transplant function of cadaver kidneys preserved with plasma perfusate containing antidonor antibody.
    Cho SI; Whelchel JD; Colberg JE
    Surgery; 1975 Oct; 78(4):472-5. PubMed ID: 1101429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for the outcome of cadaveric renal transplantation with non-heart-beating donors.
    Hiraga S; Kitamura M; Abe T; Takebayashi Y; Kakuta T; Ogawa N; Kitajima N; Hida M; Satoh T
    Transplant Proc; 1996 Feb; 28(1):209-11. PubMed ID: 8644181
    [No Abstract]   [Full Text] [Related]  

  • 38. Machine perfusion preservation for kidney grafts with a high creatinine from uncontrolled donation after cardiac death.
    Matsuno N; Konno YN; Jyojima Y; Akashi I; Iwamoto H; Hama K; Hiirano T; Nagao T
    Transplant Proc; 2010; 42(1):155-8. PubMed ID: 20172304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow and function in machine-preserved kidneys.
    Sampson D; Jun HM; Walczak P
    Br J Surg; 1978 Jan; 65(1):37-40. PubMed ID: 342039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of high-risk renal graft conditioning; functional improvement of high risk grafts by drug addition to continuous hypothermic perfusion preservation solution.
    Kozaki K; Sakurai E; Uchiyama M; Matsuno N; Kozaki M; Nagao T
    Transplant Proc; 1999 Nov; 31(7):2920-1. PubMed ID: 10578338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.